Doctor of Philosophy, Northeast Ohio Medical University, 2019, Integrated Pharmaceutical Medicine
Glaucoma, the leading cause of irreversible blindness worldwide, is a group of neurodegenerative disorders characterized by progressive and irreversible retinal ganglion cell (RGC) loss beginning with an optic neuropathy. Due to our lack of knowledge of the complicated etiology and mechanisms of glaucoma progression, no cure is available to prevent blindness. My purpose in this dissertation was to explore early contributors to glaucoma pathology in an effort to develop targeted therapy. Glaucoma is a multifactorial neurodegenerative disease in which various factors have been identified to play a significant part in its pathogenesis. For example, increased intraocular pressure can disrupt ocular blood flow to the eye, resulting in hypoxia. Although hypoxia was identified as a contributing factor for glaucoma, no one has yet identified the hypoxic cell types, hypoxia timeline and extent during glaucoma. In this dissertation, I contributed to glaucoma research by filling this gap in our knowledge to deepen our understanding of early changes after ocular hypertension. First, I determined the timeline of hypoxia in different cell types in the visual pathway using two hypoxia detection methods, an antibody against hypoxia-associated protein adducts, and a reporter protein expressed as a result of HIF1 stabilization. In addition, during hypoxia, autophagy, degradation of damaged organelles, and mitophagy, selective degradation of mitochondria, are induced. Second, I characterized hypoxia, autophagy, and oxidative stress using two models of glaucoma, the DBA/2J mouse model and a model of ocular hypertension. Finally, I used mass spectrometry to explore the half-life of mitochondrial electron transport chain complexes to better understand mitochondrial turnover, and possibly mitophagy, during glaucoma. Through these investigations, I have utilized multiple techniques, such as: Intraocular injection; intraperitoneal injection; tail vein injection; tissue sectioning using mic (open full item for complete abstract)
Committee: Denise Inman Dr. (Advisor); Brett Schofield Dr. (Committee Member); Vahagn Ohanyan Dr. (Committee Member); John Johnson Dr. (Committee Member); Samuel Crish Dr. (Committee Member)
Subjects: Neurobiology; Neurosciences